ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Figure 1Loading Img

Cytochrome P450 Oxidation of the Thiophene-Containing Anticancer Drug 3-[(Quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic Acid (4-Trifluoromethoxy-phenyl)-amide to an Electrophilic Intermediate

View Author Information
Drug Metabolism and Pharmacokinetics, OSI Pharmaceuticals, Boulder, Colorado 80301
* To whom correspondence should be addressed. Drug Metabolism and Pharmacokinetics, OSI Pharmaceuticals, Inc., 2860 Wilderness Place, Boulder, CO 80301. E-mail: [email protected]
†Present address: DMPK and Bioanalytical Services, ABC Laboratories, Inc., 7200 E. ABC Lane, Columbia, MO 65202.
‡Present address: Tucson, AZ.
Cite this: Chem. Res. Toxicol. 2008, 21, 8, 1570–1577
Publication Date (Web):August 2, 2008
Copyright © 2008 American Chemical Society

    Article Views





    Read OnlinePDF (2 MB)
    Supporting Info (1)»


    Abstract Image

    Compounds that are enzymatically transformed to reactive intermediates are common in nature. Some drugs and many phytochemicals that contain a thiophene ring are oxidized by cytochrome P450 to biological reactive intermediates (BRI) that can covalently bind to thiol nucleophiles. The investigational anticancer agent 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy-phenyl)-amide (OSI-930) contains a thiophene moiety that can be oxidized by P450s to an apparent sulfoxide, which can react via Michael-addition to the 5-position of the thiophene ring, as demonstrated by mass spectral characterization of several thioether conjugates of the presumed thiophene S-oxide. Furthermore, a stable deuterium isotope retention experiment in which solvent deuterium was incorporated into the thiophene verifies the sulfoxide pathway. Various thiol nucleophiles are shown by tandem mass spectra to bind with this BRI, which is activated by P450 3A4 and to a slight degree, P450 2D6. Yet various safe drugs, phytochemicals, and endogenous molecules, all noted for their activation to BRI, are not toxic at a normal dose. Thus, multiple features determine any consequence of a BRI, with these complexities determining why one BRI is benign while another is not. The retention of covalent protein adducts of radio-labeled intermediate rat tissue has a half-life of about 1−1.5 days; hence, modified protein is cleared and replaced relatively quickly.

    Supporting Information

    Jump To

    Results of in vivo protein covalent bonding of radio-labeled drug equivalent and clearance over a week. This material is available free of charge via the Internet at

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 34 publications.

    1. Chaitanya K. Jaladanki, Samima Khatun, Holger Gohlke, Prasad V. Bharatam. Reactive Metabolites from Thiazole-Containing Drugs: Quantum Chemical Insights into Biotransformation and Toxicity. Chemical Research in Toxicology 2021, 34 (6) , 1503-1517.
    2. Na Le Dang, Tyler B. Hughes, Grover P. Miller, and S. Joshua Swamidass . Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes. Chemical Research in Toxicology 2017, 30 (4) , 1046-1059.
    3. Chaitanya K. Jaladanki, Nikhil Taxak, Rohith A. Varikoti, and Prasad V. Bharatam . Toxicity Originating from Thiophene Containing Drugs: Exploring the Mechanism using Quantum Chemical Methods. Chemical Research in Toxicology 2015, 28 (12) , 2364-2376.
    4. Darja Gramec, Lucija Peterlin Mašič, and Marija Sollner Dolenc . Bioactivation Potential of Thiophene-Containing Drugs. Chemical Research in Toxicology 2014, 27 (8) , 1344-1358.
    5. Bo Jiang, Xing-Jun Tu, Xue Wang, Shu-Jiang Tu, and Guigen Li . Copper(I)-Catalyzed Multicomponent Reaction Providing a New Access to Fully Substituted Thiophene Derivatives. Organic Letters 2014, 16 (14) , 3656-3659.
    6. Li-Rong Wen, Tao He, Ming-Chao Lan, and Ming Li . Three-Component Cascade Annulation of β-Ketothioamides Promoted by CF3CH2OH: A Regioselective Synthesis of Tetrasubstituted Thiophenes. The Journal of Organic Chemistry 2013, 78 (21) , 10617-10628.
    7. Peter M. Rademacher, Caleb M. Woods, Qingbiao Huang, Grazyna D. Szklarz, and Sidney D. Nelson . Differential Oxidation of Two Thiophene-Containing Regioisomers to Reactive Metabolites by Cytochrome P450 2C9. Chemical Research in Toxicology 2012, 25 (4) , 895-903.
    8. Guosheng Wu, Sarvesh C. Vashishtha and John C. L. Erve . Characterization of Glutathione Conjugates of Duloxetine by Mass Spectrometry and Evaluation of in Silico Approaches to Rationalize the Site of Conjugation for Thiophene Containing Drugs. Chemical Research in Toxicology 2010, 23 (8) , 1393-1404.
    9. Derek R. Boyd, Narain D. Sharma, Paul J. Stevenson, Patrick Hoering, Christopher C. R. Allen, Patrick M. Dansette. Monooxygenase- and Dioxygenase-Catalyzed Oxidative Dearomatization of Thiophenes by Sulfoxidation, cis-Dihydroxylation and Epoxidation. International Journal of Molecular Sciences 2022, 23 (2) , 909.
    10. Chiara Pedicone, Shea T. Meyer, John D. Chisholm, William G. Kerr. Targeting SHIP1 and SHIP2 in Cancer. Cancers 2021, 13 (4) , 890.
    11. Naghmeh Faal Hamedani, Maryam Ghazvini, Fatemeh Sheikholeslami‐Farahani, Mohammad Taghi Bagherian‐Jamnani. ZnO nanorods as efficient catalyst for the green synthesis of thiophene derivatives: Investigation of antioxidant and antimicrobial activity. Journal of Heterocyclic Chemistry 2020, 57 (4) , 1588-1598.
    12. Chang-Hwei Chen. Reactive Intermediates Generated from Bioactivation. 2020, 95-108.
    13. Fengyi Zhao, Xu Sun, Wen Lu, Li Xu, Jiuzhou Shi, Shilong Yang, Mengyi Zhou, Fan Su, Feng Lin, Fuliang Cao. Synthesis of novel, DNA binding heterocyclic dehydroabietylamine derivatives as potential antiproliferative and apoptosis-inducing agents. Drug Delivery 2020, 27 (1) , 216-227.
    14. Jana Spura, Amel Farhati, Vitalijs Romanovs, Artyom Borodulin, Sergejs Belakovs, Juris Popelis, Irina Shestakova, Mohamed Dammak, Viatcheslav Jouikov. Novel R3M (M = Si, Ge) substituted furan and thiophene-derived aldimines: Synthesis, electrochemistry, and biological activity. Comptes Rendus Chimie 2019, 22 (9-10) , 686-694.
    15. Mehtap Özgür, Mehmet Yılmaz, Hiroshi Nishino, Eda Çinar Avar, Hakan Dal, A. Tarık Pekel, Tuncer Hökelek. Efficient syntheses and antimicrobial activities of new thiophene containing pyranone and quinolinone derivatives using manganese( iii ) acetate: the effect of thiophene on ring closure–opening reactions. New Journal of Chemistry 2019, 43 (15) , 5737-5751.
    16. Kate E. Slessor, Jeanette E. Stok, Sharon Chow, James J. De Voss. Significance of Protein–Substrate Hydrogen Bonding for the Selectivity of P450‐Catalysed Oxidations. Chemistry – A European Journal 2019, 25 (16) , 4149-4155.
    17. Thies Thiemann. Thiophene S-Oxides. 2019
    18. Hong‐Wei Han, Hong‐Yan Lin, De‐Liu He, Yao Ren, Wen‐Xue Sun, Li Liang, Mei‐Hang Du, Deng‐Chao Li, Yi‐Chun Chu, Min‐Kai Yang, Xiao‐Ming Wang, Yong‐Hua Yang. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation. Chemistry & Biodiversity 2018, 15 (11)
    19. Mohammed K. AbdElhameid, Madlen B. Labib, Ahmed T. Negmeldin, Muhammad Al-Shorbagy, Manal R. Mohammed. Design, synthesis, and screening of ortho- amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2018, 33 (1) , 1472-1493.
    20. Samuel M. Cohen, Shoji Fukushima, Nigel J. Gooderham, F. Peter Guengerich, Stephen S. Hecht, Ivonne M.C.M. Rietjens, Robert L. Smith, Maria Bastaki, Christie L. Harman, Margaret M. McGowen, Luis G. Valerio, Sean V. Taylor. Safety evaluation of substituted thiophenes used as flavoring ingredients. Food and Chemical Toxicology 2017, 99 , 40-59.
    21. B. Janaki Ramulu, Suvajit Koley, Maya Shankar Singh. Metal-free Brønsted acid mediated synthesis of fully substituted thiophenes via chemo- and regioselective intramolecular cyclization of α,α′-bis(β-oxodithioesters) at room temperature. Organic & Biomolecular Chemistry 2016, 14 (2) , 434-439.
    22. Wenjuan Shi, Li Wan, Yimin Hu, Shaofa Sun, Wenjun Li, Yanhong Peng, Minghu Wu, Haibing Guo, Jian Wang. Facile synthesis of 3-aldehyde-2-substituted thiophenes through Lewis base catalyzed [3+2] cycloaddition of 1,4-dithiane-2,5-diols with ynals. Tetrahedron Letters 2015, 56 (16) , 2083-2085.
    23. Satya Narayan Sahu, Maneesh Kumar Gupta, Surjeet Singh, Pratik Yadav, Rahul Panwar, Abhinav Kumar, Vishnu Ji Ram, Brijesh Kumar, Ramendra Pratap. One pot synthesis of tetrasubstituted thiophenes: [3 + 2] annulation strategy. RSC Advances 2015, 5 (46) , 36979-36986.
    24. F. Peter Guengerich, Emre M. Isin. Unusual Metabolic Reactions and Pathways. 2014, 1-51.
    25. Richa Goel, Vijay Luxami, Kamaldeep Paul. Palladium catalyzed novel monoarylation and symmetrical/unsymmetrical diarylation of imidazo[1,2-a]pyrazines and their in vitro anticancer activities. RSC Advances 2014, 4 (19) , 9885.
    26. David C. Evans. Covalent Drug–Protein Adducts: An Exploration of Their Role in Drug‐Induced Liver and General Organ Toxicity. 2012, 1-45.
    27. Akiyoshi Mochizuki, Tsutomu Nagata, Hideyuki Kanno, Daisuke Takano, Masamichi Kishida, Makoto Suzuki, Toshiharu Ohta. Orally active zwitterionic factor Xa inhibitors with long duration of action. Bioorganic & Medicinal Chemistry Letters 2011, 21 (24) , 7337-7343.
    28. Chun Yip Chan, Lee Sun New, Han Kiat Ho, Eric Chun Yong Chan. Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation. Toxicology Letters 2011, 206 (3) , 314-324.
    29. Hsia-lien Lin, Haoming Zhang, Christine Medower, Paul F. Hollenberg, William W. Johnson. Inactivation of Cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a Thiophene-Containing Anticancer Drug. Drug Metabolism and Disposition 2011, 39 (2) , 345-350.
    30. Graham F. Smith. Designing Drugs to Avoid Toxicity. 2011, 1-47.
    31. Yiding Hu, Shengtian Yang, F. Barclay Shilliday, Bruce R. Heyde, Kathy M. Mandrell, Russell H. Robins, Jin Xie, Matthew T. Reding, Yurong Lai, David C. Thompson. Novel Metabolic Bioactivation Mechanism for a Series of Anti-Inflammatory Agents (2,5-Diaminothiophene Derivatives) Mediated by Cytochrome P450 Enzymes. Drug Metabolism and Disposition 2010, 38 (9) , 1522-1531.
    32. Qian Miao, Xiaowei Yan, Kejian Zhao. Synthesis, Structure and Anticancer Activity Studies of 1‐[(5‐Bromo‐2‐thienyl)sulfonyl]‐5‐fluoro‐1,2,3,4‐tetrahydropyrimidine‐2,4‐dione. Chinese Journal of Chemistry 2010, 28 (1) , 81-85.
    33. Shinji Shimizu, Ryo Atsumi, Tsunenori Nakazawa, Yuko Fujimaki, Kenichi Sudo, Osamu Okazaki. Metabolism of Ticlopidine in Rats: Identification of the Main Biliary Metabolite as a Glutathione Conjugate of Ticlopidine S -Oxide. Drug Metabolism and Disposition 2009, 37 (9) , 1904-1915.
    34. Bernard P. Murray. Chapter 26 Mechanism-Based Inhibition of CYP3A4 and Other Cytochromes P450. 2009, 535-553.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect